Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr 6;60(4):1580-1581.
doi: 10.1093/rheumatology/keaa889.

COVID-19 and mortality in rare rheumatic diseases, a warning bell?

Affiliations
Editorial

COVID-19 and mortality in rare rheumatic diseases, a warning bell?

James Galloway et al. Rheumatology (Oxford). .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Gianfrancesco M, Hyrich KL, Al-Adely S et al. ; COVID-19 Global Rheumatology Alliance. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 2020;79:859–66. - PMC - PubMed
    1. Favalli EG, Ingegnoli F, De Lucia O et al. COVID-19 infection and rheumatoid arthritis: faraway, so close! Autoimmun Rev 2020;19:102523. - PMC - PubMed
    1. Monti S, Balduzzi S, Delvino P et al. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis 2020;79:667–8. - PMC - PubMed
    1. Favalli EG, Monti S, Ingegnoli F et al. Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? Arthritis Rheumatol 2020;72:1600–6. - PMC - PubMed
    1. Peach E, Rutter M, Lanyon P, Grainge et al. Risk of death among people with rare autoimmune diseases compared to the general population in England during the 2020 COVID-19 pandemic. Rheumatology (Oxford) 2020; (in press). - PMC - PubMed